CEO Today Healthcare Awards

www.ceotodaymagazine.com CEO Today Healthcare Awards 2019 34 FRANCE FIRM PROFILE We, at Sanofi, are there beside people in need, as a health journey partner Healthcare solutions Life is a health journey with its ups and downs, and its challenges. These can be big or small, lifelong or momentary. Everyone, from children to elder people can be facing health challenges and needs, wherever they are. Health & Well-being We believe that empowering individuals, the community and healthcare professionals to promote and practice self-care, will lead to people all over the world being healthier. Our self-care solutions cover cough and cold, allergies, digestive health, nutritionals and pain care. Diabetes and Cardiovascular diseases With the development of more sedentary lifestyles, diabetes and cardiovascular diseases have become global public health issues. As a journey partner, our purpose is to help people with diabetes and cardiovascular diseases improve their quality of life. Oncology We have a strong heritage in oncology and are committed to finding new pathways to treat people affected by the disease and improve their quality of life. We, at Sanofi, believe that open innovation will help develop new approaches and expertise to discover targeted treatments against cancer. Immunology At Sanofi, we are exploring new ways to support people affected by immune diseases and make a difference in their lives. We are committed to improving their quality of life. Multiple Sclerosis At Sanofi, we are committed to being partner of the multiple sclerosis community and have been working for over a decade on the development of treatments for multiple sclerosis. We continue to focus our research efforts in areas such as early-stage research programs that focus on preventing and repairing the damage to the nervous system caused by multiple sclerosis. Rare diseases The rarity and complexity of patients’ medical conditions can make a rare disease difficult to diagnose and treat, leaving patients feeling isolated. At Sanofi, we are committed to empowering the lives of people with rare diseases and continue to focus on being transformative in rare diseases. PAUL HUDSON CEO of Sanofi ABOUT PAUL HUDSON Paul Hudson joined Sanofi as CEO on September 1, 2019. Previously CEO of Novartis Pharmaceuticals (2016-2019), where he was a member of the Executive Committee, Paul has an expansive international career in healthcare that spans the U.S., Japan and Europe. Prior to Novartis, he worked for AstraZeneca, where he held several increasingly senior positions and most recently carried out the roles of president, AstraZeneca United States and executive vice president, North America. He began his career in sales and marketing roles at GlaxoSmithKline UK and Sanofi-Synthélabo U.K. Paul holds a degree in economics from Manchester Metropolitan University in the U.K. and last year his alma mater awarded him an honorary Doctor of Business Administration for his achievements in industry. He also holds a diploma in marketing from the Chartered Institute of Marketing, also in the U.K. “People are what drive me. I was drawn to healthcare so that I could positively impact people’s lives. As a leader, I firmly believe that making an impact starts within–how we do things, how we work with integrity, and how we empower and inspire each other to bring our best selves to work. Even on a tough day, I can be confident that our work has a positive impact on people–either by improving a patient’s life or by inspiring a colleague.” - Paul Hudson www.sanofi.com